HZNP

Horizon Therapeutics Public Limited Company

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

62.12

p/bv

5.12

DIVIDEND YIELD

0.00%

HZNP price

Horizon Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment HZNP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals HZNP

Valuation

P/E

62.12

Sector -3.50

Industry -3.50

P/BV

5.12

Sector 2.02

Industry 2.02

P/Revenue (PSR)

7.47

Sector 2.01

Industry 2.01

EV/EBITDA

188.13

Sector -214.99

Industry -214.99

EV/EBIT

559.79

Sector -47.59

Industry -47.59

P/EBITDA

53.19

Sector -21.41

Industry -21.41

P/EBIT

222.15

Sector -28.65

Industry -28.65

P/Total Assets

2.93

Sector 1.19

Industry 1.19

P/Net Current Assets

Sector -11.97

Industry -11.97

P/Working Capital

Sector -167.95

Industry -167.95

EPS

1.87

Sector -1.81

Industry -1.81

BVPS

22.70

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

75.21%

Sector 41.30%

Industry 41.30%

EBITDA Margin

15.35%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

5.16%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

14.09%

Sector -35.21%

Industry -35.21%

Net Profit Margins

12.02%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.10

Sector 0.02

Industry 0.02

Profitability

ROE

8.25%

Sector -56.04%

Industry -56.04%

ROA

4.71%

Sector -60.31%

Industry -60.31%

ROIC

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

Sector 2.89

Industry 2.89

Net Debt / EBITDA

0.53

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

1.58

Sector -8.06

Industry -8.06

Net Debt / Equity

0.01

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.48

Sector -0.85

Industry -0.85

Equity/Assets

0.57

Sector 0.46

Industry 0.46

Liabilities/Assets

0.57

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

2.47%

Sector -

Industry -

5Y Earnings CAGR

-3.90%

Sector -

Industry -

Fundamentals HZNP

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF Horizon Therapeutics ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$0.00

Fair Value

$30.90

Upside

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
HZNP Horizon Therapeutics Public Limited Company	$0.00	-	0.00%	62.12	5.12	8.25%	12.02%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

HZNP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Horizon Therapeutics

Horizon Therapeutics Public Limited Company

Average Investor10 user rating

4.0 (0 people)

United States

16 years

Founded: 2010

2011

Time since IPO - 15 years

1.395

Employees

Horizon Therapeutics Public Limited Company (United States) is listed on the Nasdaq and has a market capitalization of $27.21 billion, with shareholders equity totaling $5.31 billion.

The company employs approximately 1.395 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Horizon Therapeutics Public Limited Company reported $3.64 billion in revenue, generating net income of $438.00 million.

Key financial metrics include a P/E ratio of 62.12, a price-to-book (P/B) ratio of 5.12, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker HZNP.

Market cap

$27.21 billion

Net worth

$5.31 billion

$5,310,959,000.00

Assets

$9.30 billion

$9,298,741,000.00

Total Shares Outstanding

233.94 million

233,935,000

Average Daily Trading Volume

$3.10 million

$3,102,212.66

Sector

Health Care

Industry

Biotechnology

HZNP

HZNP revenue and profits

Financial Results HZNP

DRAG THE FRAME TO SEE MORE DATA

HZNP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Horizon Therapeutics (HZNP) today?

A cotação de Horizon Therapeutics (HZNP) hoje está em US$ 0.00, com uma variação de 0% em relação ao último ano. A cotação de Horizon Therapeutics (HZNP) iniciou o ano negociando na casa dos US$ 0.00 e hoje está em US$ 0.00. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Horizon Therapeutics (HZNP) e dados de ações do Ibovespa e mercados internacionais.

Quando Horizon Therapeutics (HZNP) paga dividendos?

Horizon Therapeutics (HZNP) não distribuiu dividendos no último ano.

Is Horizon Therapeutics (HZNP) a good investment?

Atualmente, Horizon Therapeutics (HZNP) está cotada a US$ 0.00, com um P/L de 62.12, representando um desvio de 5,649% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 0 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 0.00%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Horizon Therapeutics (HZNP) stock?

Investir em ações de Horizon Therapeutics (HZNP) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Horizon Therapeutics (HZNP) yield today?

A rentabilidade de Horizon Therapeutics (HZNP) foi de 0.00% no último mês, 0.00% no último ano e 0.00% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Horizon Therapeutics (HZNP) hoje, o investimento total seria de US$ 0.00, com base na cotação atual de US$ 0.00.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 0.00
Em 5 anos: US$ 0.00
Em 10 anos: US$ 0.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

HZNP

Horizon Therapeutics Public Limited Company

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment HZNP

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING HZNP WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Horizon Therapeutics

Horizon Therapeutics Public Limited Company

United States

16 years

2011

1.395

PROFIT X PRICE HZNP

Financial Results HZNP

HZNP cash flow

Asset, Revenue and Profit Growth - HZNP

HZNP balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions